O
BSX icon

OppenheimerFunds’s Boston Scientific BSX Stock Holding History

OppenheimerFunds’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$217M Sell
5,652,397
-462,003
-8% -$17.6M 0.27% 94
2018
Q4 		$216M Sell
6,114,400
-294,510
-5% -$10.7M 0.31% 92
2018
Q3 		$247M Sell
6,408,910
-805,079
-11% -$28.1M 0.29% 94
2018
Q2 		$236M Sell
7,213,989
-703,929
-9% -$21.2M 0.28% 95
2018
Q1 		$216M Sell
7,917,918
-58,622
-0.7% -$1.59M 0.27% 101
2017
Q4 		$198M Buy
7,976,540
+824,195
+12% +$22.7M 0.24% 113
2017
Q3 		$209M Sell
7,152,345
-404,147
-5% -$11.2M 0.26% 99
2017
Q2 		$209M Sell
7,556,492
-948,104
-11% -$25.2M 0.26% 101
2017
Q1 		$212M Sell
8,504,596
-335,653
-4% -$8.16M 0.26% 107
2016
Q4 		$191M Sell
8,840,249
-23,488
-0.3% -$512K 0.24% 117
2016
Q3 		$211M Sell
8,863,737
-192,805
-2% -$4.6M 0.26% 103
2016
Q2 		$212M Sell
9,056,542
-4,351,081
-32% -$94.1M 0.28% 100
2016
Q1 		$252M Buy
13,407,623
+836,272
+7% +$14.7M 0.33% 77
2015
Q4 		$232M Sell
12,571,351
-1,010,812
-7% -$18.1M 0.29% 89
2015
Q3 		$223M Buy
13,582,163
+886,006
+7% +$15.1M 0.3% 91
2015
Q2 		$225M Buy
12,696,157
+4,038,548
+47% +$72.2M 0.26% 108
2015
Q1 		$154M Buy
8,657,609
+7,776,672
+883% +$123M 0.17% 158
2014
Q4 		$11.7M Sell
880,937
-690,650
-44% -$8.83M 0.01% 730
2014
Q3 		$18.6M Sell
1,571,587
-458,650
-23% -$5.78M 0.02% 586
2014
Q2 		$25.9M Hold
2,030,237
– – 0.03% 513
2014
Q1 		$27.4M Sell
2,030,237
-646,420
-24% -$8.48M 0.03% 497
2013
Q4 		$32.2M Sell
2,676,657
-3,023,977
-53% -$35.7M 0.04% 447
2013
Q3 		$66.9M Buy
5,700,634
+2,134,207
+60% +$23.1M 0.04% 409
2013
Q2 		$33.1M Buy
+3,566,427
New +$30.3M 0.05% 411

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

OppenheimerFunds's BSX Position: Q1 2019 in Review

OppenheimerFunds reduced its Boston Scientific (BSX) stake by 7.6% in Q1 2019, selling an estimated $17.6M and leaving 5,652,397 shares worth $217M. The position accounts for 0.27% of the portfolio, ranked #94.

OppenheimerFunds first reported a position in BSX in Q2 2013 and has held it in 24 quarters since. The position peaked at $252M in Q1 2016. 789 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • OppenheimerFunds held 5,652,397 shares of Boston Scientific worth $217M as of Q1 2019.
  • OppenheimerFunds sold 462,003 Boston Scientific shares in Q1 2019, an estimated $17.6M.
  • Boston Scientific made up 0.27% of OppenheimerFunds's portfolio in Q1 2019, its #94 holding.
  • OppenheimerFunds first reported a position in Boston Scientific in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Boston Scientific position peaked at $252M in Q1 2016.
  • 789 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.